SQ
SQZ Biotechnologies Company
SQZB · OTC
$0.02 +0.00% (+$0.00)
1M +0.00%
Market Cap $707.8K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
1/9Valuation
100 /100
Cheap P/B 0.01x
P/S 0.03x
EV/FFO N/A
Growth
26 /100
Declining Book val. growth 0.83%
Rev. growth 1.50%
FCF growth N/A
Profitability
19 /100
Weak Op. margin 383.68%
Gross margin 46.57%
FCF margin 399.79%
Quality
3 /100
Poor Asset turnover 0.20x
ROIC 81.66%
ROA 74.14%
Debt
91 /100
Low Net debt/EBITDA 0.46x
Debt/Equity 0.60x
Current ratio 3.12x
Stability
44 /100
Moderate EPS volatility 23.36%
Beta 0.32x
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about SQZB
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Howard Bernstein
Employees
53
Headquarters
Watertown
Upcoming events
12 NOV
Earnings
Upcoming earnings report